Literature DB >> 26133374

Anthropometric Risk Factors for Differentiated Thyroid Cancer in Young Men and Women From Eastern France: A Case-Control Study.

Constance Xhaard, Florent de Vathaire, Enora Cléro, Stéphane Maillard, Yan Ren, Françoise Borson-Chazot, Geneviève Sassolas, Claire Schvartz, Marc Colonna, Brigitte Lacour, Arlette Danzon, Michel Velten, Emilie Marrer, Laurent Bailly, Eugènia Mariné Barjoan, Martin Schlumberger, Jacques Orgiazzi, Elisabeth Adjadj, Carole Rubino.   

Abstract

The incidence of thyroid cancer has risen over the past decade, along with a rise in obesity. We studied the role of anthropometric risk factors for differentiated thyroid cancer at the time of diagnosis and at age 20 years in a case-control study conducted in eastern France between 2005 and 2010. The study included 761 adults diagnosed with differentiated thyroid cancer before 35 years of age between 2002 and 2006. They were matched with 825 controls from the general population. Odds ratios were calculated using conditional logistic regression models and were reported for all participants, those with papillary cancer only, and women only. The risk of thyroid cancer was higher for participants with a high body surface area (BSA), great height, or excess weight and for women with a high body fat percentage. Conversely, no significant association was found between body mass index and the risk of thyroid cancer. In the present study, we provide further evidence of the role of BSA and excess weight in the risk of thyroid cancer. These epidemiologic observations should be confirmed by further exploration of the biological mechanisms responsible for the associations of obesity and BSA with thyroid cancer.
© The Author 2015. Published by Oxford University Press on behalf of the Johns Hopkins Bloomberg School of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  anthropometric risk factors; body surface area; case-control study; obesity; thyroid cancer

Mesh:

Year:  2015        PMID: 26133374     DOI: 10.1093/aje/kwv048

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  8 in total

1.  Recreational Physical Activity and Differentiated Thyroid Cancer Risk: A Pooled Analysis of Two Case-Control Studies.

Authors:  Constance Xhaard; Juan J Lence-Anta; Yan Ren; Françoise Borson-Chazot; Geneviève Sassolas; Claire Schvartz; Marc Colonna; Brigitte Lacour; Arlette Danzon; Michel Velten; Enora Clero; Stéphane Maillard; Emilie Marrer; Laurent Bailly; Eugènia Mariné Barjoan; Martin Schlumberger; Jacques Orgiazzi; Elisabeth Adjadj; Celia M Pereda; Silvia Turcios; Milagros Velasco; Mae Chappe; Idalmis Infante; Marlene Bustillo; Anabel García; Sirced Salazar; Regla Rodriguez; Mohamed Amine Benadjaoud; Rosa M Ortiz; Carole Rubino; Florent de Vathaire
Journal:  Eur Thyroid J       Date:  2016-05-21

2.  Association between vitamin D deficiency and risk of thyroid cancer: a case-control study and a meta-analysis.

Authors:  M-J Hu; Q Zhang; L Liang; S-Y Wang; X-C Zheng; M-M Zhou; Y-W Yang; Q Zhong; F Huang
Journal:  J Endocrinol Invest       Date:  2018-02-20       Impact factor: 4.256

3.  Adapted dietary inflammatory index and differentiated thyroid carcinoma risk in two French population-based case-control studies.

Authors:  Marie-Christine Boutron-Ruault; Thérèse Truong; Lucie Lécuyer; Nasser Laouali; Mariem Hajji-Louati; Melanie Paquet; Vincent Souchard; Mojgan Karimi; Claire Schvartz; Anne-Valérie Guizard; Constance Xhaard; Carole Rubino; Yan Ren; Françoise Borson-Chazot; Elisabeth Adjadj; Emilie Cordina-Duverger; Florent De Vathaire; Pascal Guénel
Journal:  Eur J Nutr       Date:  2021-10-31       Impact factor: 5.614

4.  Dietary habits during the 2 months following the Chernobyl accident and differentiated thyroid cancer risk in a population-based case-control study.

Authors:  Constance Xhaard; Carole Rubino; Vincent Souchard; Stéphane Maillard; Yan Ren; Françoise Borson-Chazot; Geneviève Sassolas; Claire Schvartz; Marc Colonna; Brigitte Lacour; Anne Sophie Woronoff; Michel Velten; Emilie Marrer; Laurent Bailly; Eugènia Mariné Barjoan; Martin Schlumberger; Vladimir Drozdovitch; Andre Bouville; Jacques Orgiazzi; Elisabeth Adjadj; Florent de Vathaire
Journal:  Cancer Epidemiol       Date:  2018-01-08       Impact factor: 2.890

5.  Gene network and biological pathways associated with susceptibility to differentiated thyroid carcinoma.

Authors:  Thérèse Truong; Fabienne Lesueur; Om Kulkarni; Pierre-Emmanuel Sugier; Julie Guibon; Anne Boland-Augé; Christine Lonjou; Delphine Bacq-Daian; Robert Olaso; Carole Rubino; Vincent Souchard; Frédérique Rachedi; Juan Jesus Lence-Anta; Rosa Maria Ortiz; Constance Xhaard; Pierre Laurent-Puig; Claire Mulot; Anne-Valérie Guizard; Claire Schvartz; Marie-Christine Boutron-Ruault; Evgenia Ostroumova; Ausrele Kesminiene; Jean-François Deleuze; Pascal Guénel; Florent De Vathaire
Journal:  Sci Rep       Date:  2021-04-26       Impact factor: 4.379

6.  Fine-mapping of two differentiated thyroid carcinoma susceptibility loci at 2q35 and 8p12 in Europeans, Melanesians and Polynesians.

Authors:  Julie Guibon; Pierre-Emmanuel Sugier; Om Kulkarni; Mojgan Karimi; Delphine Bacq-Daian; Céline Besse; Anne Boland; Elisabeth Adjadj; Frédérique Rachédi; Carole Rubino; Constance Xhaard; Claire Mulot; Pierre Laurent-Puig; Anne-Valérie Guizard; Claire Schvartz; Rosa Maria Ortiz; Yan Ren; Evgenia Ostroumova; Jean-François Deleuze; Marie-Christine Boutron-Ruault; Ausrele Kesminiene; Florent De Vathaire; Pascal Guénel; Fabienne Lesueur; Thérèse Truong
Journal:  Oncotarget       Date:  2021-03-02

7.  Incidence, detection and outcome of differentiated thyroid cancer in Western Sweden.

Authors:  J Dahlberg; C Adok; P Bümming; A Demir; G Hedbäck; B Nilsson; M Nilsson; S Jansson
Journal:  BJS Open       Date:  2021-09-06

Review 8.  Impaired Glucose Metabolism, Anti-Diabetes Medications, and Risk of Thyroid Cancer.

Authors:  Yevgeniya Kushchayeva; Sergiy Kushchayev; Kirk Jensen; Rebecca J Brown
Journal:  Cancers (Basel)       Date:  2022-01-22       Impact factor: 6.639

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.